Bionano Genomics Inc (BNGO)
1.16
+0.05
(+4.50%)
USD |
NASDAQ |
May 15, 15:43
Bionano Genomics Cash from Operations (Quarterly): -28.13M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -28.13M |
| December 31, 2023 | -29.78M |
| September 30, 2023 | -26.29M |
| June 30, 2023 | -36.70M |
| March 31, 2023 | -32.41M |
| December 31, 2022 | -34.52M |
| September 30, 2022 | -29.47M |
| June 30, 2022 | -28.33M |
| March 31, 2022 | -32.49M |
| December 31, 2021 | -25.62M |
| September 30, 2021 | -19.98M |
| June 30, 2021 | -12.42M |
| March 31, 2021 | -13.90M |
| December 31, 2020 | -12.10M |
| September 30, 2020 | -10.96M |
| Date | Value |
|---|---|
| June 30, 2020 | -7.218M |
| March 31, 2020 | -8.032M |
| December 31, 2019 | -9.382M |
| September 30, 2019 | -7.28M |
| June 30, 2019 | -6.316M |
| March 31, 2019 | -6.552M |
| December 31, 2018 | -4.090M |
| September 30, 2018 | -6.100M |
| June 30, 2018 | -2.966M |
| March 31, 2018 | -6.788M |
| December 31, 2017 | -2.809M |
| September 30, 2017 | -5.655M |
| June 30, 2017 | -4.988M |
| March 31, 2017 | -7.366M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-36.70M
Minimum
Jun 2023
-6.316M
Maximum
Jun 2019
-20.57M
Average
-22.80M
Median
Cash from Operations (Quarterly) Benchmarks
| Bruker Corp | 21.80M |
| Azenta Inc | 8.356M |
| Harvard Bioscience Inc | 1.403M |
| Akoya Biosciences Inc | -5.584M |
| Singular Genomics Systems Inc | -18.90M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 47.59M |
| Cash from Financing (Quarterly) | -21.62M |
| Free Cash Flow | -122.26M |
| Free Cash Flow Per Share (Quarterly) | -0.5339 |
| Free Cash Flow to Equity (Quarterly) | 12.57M |
| Free Cash Flow to Firm (Quarterly) | -28.16M |
| Free Cash Flow Yield | -322.4% |